TY - JOUR AU - Benjamin, E. J. AU - Levy, D. AU - Vaziri, S. M. AU - D'Agostino, R. B. AU - Belanger, A. J. AU - Wolf, P. A. PY - 1994 DA - 1994// TI - Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham heart study JO - JAMA VL - 271 UR - https://doi.org/10.1001/jama.1994.03510350050036 DO - 10.1001/jama.1994.03510350050036 ID - Benjamin1994 ER - TY - STD TI - Whalen K: Lippincott Illustrated Reviews of Pharmacology: Wolter Kluwer. In.; 2015. ID - ref2 ER - TY - STD TI - Katzung B: Basic & clinical pharmacology. In: McGraw-Hill Education. 2018. ID - ref3 ER - TY - JOUR AU - Puri, R. AU - Auffret, V. AU - Rodes-Cabau, J. PY - 2017 DA - 2017// TI - Bioprosthetic valve thrombosis JO - J Am Coll Cardiol VL - 69 UR - https://doi.org/10.1016/j.jacc.2017.02.051 DO - 10.1016/j.jacc.2017.02.051 ID - Puri2017 ER - TY - JOUR AU - Nishimura, R. A. AU - Otto, C. M. AU - Bonow, R. O. AU - Carabello, B. A. AU - Erwin, J. P. AU - Guyton, R. A. AU - O'Gara, P. T. AU - Ruiz, C. E. AU - Skubas, N. J. AU - Sorajja, P. PY - 2014 DA - 2014// TI - 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines JO - J Am Coll Cardiol VL - 63 UR - https://doi.org/10.1016/j.jacc.2014.02.536 DO - 10.1016/j.jacc.2014.02.536 ID - Nishimura2014 ER - TY - STD TI - Ezekowitz MD, Connolly S, Parekh A, Reilly PA, Varrone J, Wang S, Oldgren J, Themeles E, Wallentin L, Yusuf S: Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J 2009, 157(5):805–810, 810.e801–802. ID - ref6 ER - TY - JOUR AU - Breithardt, G. AU - Baumgartner, H. AU - Berkowitz, S. D. AU - Hellkamp, A. S. AU - Piccini, J. P. AU - Stevens, S. R. AU - Lokhnygina, Y. AU - Patel, M. R. AU - Halperin, J. L. AU - Singer, D. E. PY - 2014 DA - 2014// TI - Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial JO - Eur Heart J VL - 35 UR - https://doi.org/10.1093/eurheartj/ehu305 DO - 10.1093/eurheartj/ehu305 ID - Breithardt2014 ER - TY - JOUR AU - Avezum, A. AU - Lopes, R. D. AU - Schulte, P. J. AU - Lanas, F. AU - Gersh, B. J. AU - Hanna, M. AU - Pais, P. AU - Erol, C. AU - Diaz, R. AU - Bahit, M. C. PY - 2015 DA - 2015// TI - Apixaban in comparison with warfarin in patients with atrial fibrillation and Valvular heart disease: findings from the Apixaban for reduction in stroke and other Thromboembolic events in atrial fibrillation (ARISTOTLE) trial JO - Circulation VL - 132 UR - https://doi.org/10.1161/CIRCULATIONAHA.114.014807 DO - 10.1161/CIRCULATIONAHA.114.014807 ID - Avezum2015 ER - TY - JOUR AU - Lopes, R. D. AU - Alexander, J. H. AU - Al-Khatib, S. M. AU - Ansell, J. AU - Diaz, R. AU - Easton, J. D. AU - Gersh, B. J. AU - Granger, C. B. AU - Hanna, M. AU - Horowitz, J. PY - 2010 DA - 2010// TI - Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale JO - Am Heart J VL - 159 UR - https://doi.org/10.1016/j.ahj.2009.07.035 DO - 10.1016/j.ahj.2009.07.035 ID - Lopes2010 ER - TY - JOUR AU - Caterina, R. AU - Renda, G. AU - Carnicelli, A. P. AU - Nordio, F. AU - Trevisan, M. AU - Mercuri, M. F. AU - Ruff, C. T. AU - Antman, E. M. AU - Braunwald, E. AU - Giugliano, R. P. PY - 2017 DA - 2017// TI - Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial JO - J Am Coll Cardiol VL - 69 UR - https://doi.org/10.1016/j.jacc.2016.12.031 DO - 10.1016/j.jacc.2016.12.031 ID - Caterina2017 ER - TY - JOUR AU - Ruff, C. T. AU - Giugliano, R. P. AU - Antman, E. M. AU - Crugnale, S. E. AU - Bocanegra, T. AU - Mercuri, M. AU - Hanyok, J. AU - Patel, I. AU - Shi, M. AU - Salazar, D. PY - 2010 DA - 2010// TI - Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the effective aNticoaGulation with factor xA next GEneration in atrial fibrillation-thrombolysis in myocardial infarction study 48 (ENGAGE AF-TIMI 48) JO - Am Heart J VL - 160 UR - https://doi.org/10.1016/j.ahj.2010.06.042 DO - 10.1016/j.ahj.2010.06.042 ID - Ruff2010 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000097 DO - 10.1371/journal.pmed.1000097 ID - Moher2009 ER - TY - JOUR AU - Higgins, J. P. T. AU - Altman, D. G. AU - Gøtzsche, P. C. AU - Jüni, P. AU - Moher, D. AU - Oxman, A. D. AU - Savović, J. AU - Schulz, K. F. AU - Weeks, L. AU - Sterne, J. A. C. PY - 2011 DA - 2011// TI - The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d5928 DO - 10.1136/bmj.d5928 ID - Higgins2011 ER - TY - JOUR AU - Sterne, J. A. AU - Sutton, A. J. AU - Ioannidis, J. P. AU - Terrin, N. AU - Jones, D. R. AU - Lau, J. AU - Carpenter, J. AU - Rucker, G. AU - Harbord, R. M. AU - Schmid, C. H. PY - 2011 DA - 2011// TI - Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials JO - Bmj VL - 343 UR - https://doi.org/10.1136/bmj.d4002 DO - 10.1136/bmj.d4002 ID - Sterne2011 ER - TY - JOUR AU - Harbord, R. M. AU - Egger, M. AU - Sterne, J. A. PY - 2006 DA - 2006// TI - A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints JO - Stat Med VL - 25 UR - https://doi.org/10.1002/sim.2380 DO - 10.1002/sim.2380 ID - Harbord2006 ER - TY - JOUR AU - Seeger, J. AU - Gonska, B. AU - Rodewald, C. AU - Rottbauer, W. AU - Wohrle, J. PY - 2017 DA - 2017// TI - Apixaban in patients with atrial fibrillation after Transfemoral aortic valve replacement JO - JACC Cardiovascular interventions VL - 10 UR - https://doi.org/10.1016/j.jcin.2016.10.023 DO - 10.1016/j.jcin.2016.10.023 ID - Seeger2017 ER - TY - JOUR AU - Geis, N. A. AU - Kiriakou, C. AU - Chorianopoulos, E. AU - Uhlmann, L. AU - Katus, H. A. AU - Bekeredjian, R. PY - 2018 DA - 2018// TI - NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation JO - Clin Res Cardiol VL - 107 UR - https://doi.org/10.1007/s00392-018-1247-x DO - 10.1007/s00392-018-1247-x ID - Geis2018 ER - TY - BOOK AU - Kontopantelis, E. AU - Reeves, D. PY - 2019 DA - 2019// TI - Pairwise meta-analysis of aggregate data using metaan in Stata ID - Kontopantelis2019 ER - TY - JOUR AU - Ezekowitz, M. D. AU - Nagarakanti, R. AU - Noack, H. AU - Brueckmann, M. AU - Litherland, C. AU - Jacobs, M. AU - Clemens, A. AU - Reilly, P. A. AU - Connolly, S. J. AU - Yusuf, S. PY - 2016 DA - 2016// TI - Comparison of dabigatran and warfarin in patients with atrial fibrillation and Valvular heart disease: the RE-LY trial (randomized evaluation of long-term anticoagulant therapy) JO - Circulation VL - 134 UR - https://doi.org/10.1161/CIRCULATIONAHA.115.020950 DO - 10.1161/CIRCULATIONAHA.115.020950 ID - Ezekowitz2016 ER - TY - JOUR AU - Breithardt, G. AU - Baumgartner, H. AU - Berkowitz, S. D. AU - Hellkamp, A. S. AU - Piccini, J. P. AU - Lokhnygina, Y. AU - Halperin, J. L. AU - Singer, D. E. AU - Hankey, G. J. AU - Hacke, W. PY - 2016 DA - 2016// TI - Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban JO - Heart VL - 102 UR - https://doi.org/10.1136/heartjnl-2015-308120 DO - 10.1136/heartjnl-2015-308120 ID - Breithardt2016 ER - TY - STD TI - Holster IL, Valkhoff VE, Kuipers EJ, Tjwa E: New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology 2013, 145(1):105–112.e115. ID - ref21 ER - TY - JOUR AU - Jaffer, I. H. AU - Stafford, A. R. AU - Fredenburgh, J. C. AU - Whitlock, R. P. AU - Weitz, J. I. PY - 2015 DA - 2015// TI - Comparison of the effect of non-vitamin k antagonist oral anticoagulants and warfarin on mechanical heart valve-induced thrombin GENERATION JO - Can J Cardiol VL - 31 UR - https://doi.org/10.1016/j.cjca.2015.07.420 DO - 10.1016/j.cjca.2015.07.420 ID - Jaffer2015 ER - TY - JOUR AU - Eikelboom, J. W. AU - Connolly, S. J. AU - Brueckmann, M. AU - Granger, C. B. AU - Kappetein, A. P. AU - Mack, M. J. AU - Blatchford, J. AU - Devenny, K. AU - Friedman, J. AU - Guiver, K. PY - 2013 DA - 2013// TI - Dabigatran versus warfarin in patients with mechanical heart valves JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1300615 DO - 10.1056/NEJMoa1300615 ID - Eikelboom2013 ER - TY - JOUR AU - Sun, J. C. AU - Davidson, M. J. AU - Lamy, A. AU - Eikelboom, J. W. PY - 2009 DA - 2009// TI - Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends JO - Lancet (London, England) VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60780-7 DO - 10.1016/S0140-6736(09)60780-7 ID - Sun2009 ER - TY - JOUR AU - Kumar, V. AU - Kelly, S. AU - Raizada, A. AU - Yee, J. AU - Anuwatworn, A. AU - Stys, A. AU - Stys, M. PY - 2017 DA - 2017// TI - Mechanical valve thrombosis on rivaroxaban: are novel anticoagulants really an option? JO - Methodist DeBakey cardiovascular journal VL - 13 UR - https://doi.org/10.14797/mdcj-13-2-73 DO - 10.14797/mdcj-13-2-73 ID - Kumar2017 ER - TY - JOUR AU - Makkar, R. R. AU - Fontana, G. AU - Jilaihawi, H. AU - Chakravarty, T. AU - Kofoed, K. F. AU - Backer, O. AU - Asch, F. M. AU - Ruiz, C. E. AU - Olsen, N. T. AU - Trento, A. PY - 2015 DA - 2015// TI - Possible subclinical leaflet thrombosis in bioprosthetic aortic valves JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1509233 DO - 10.1056/NEJMoa1509233 ID - Makkar2015 ER - TY - JOUR AU - Lefèvre, T. PY - 2016 DA - 2016// TI - Anticoagulation treatment after Transcatheter aortic valve replacement JO - J Am Coll Cardiol Intv VL - 9 UR - https://doi.org/10.1016/j.jcin.2016.07.017 DO - 10.1016/j.jcin.2016.07.017 ID - Lefèvre2016 ER - TY - BOOK AU - Kumar, P. C. AU - Clark, M. PY - 2017 DA - 2017// TI - Clinical medicine PB - Bailliere Tindall CY - London ID - Kumar2017 ER -